Editas Medicine (EDIT) EBITDA Margin Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.66 Mn |
| Jun 30, 2025 | -58,811.00 |
| Mar 31, 2025 | -88,558.00 |
| Dec 31, 2024 | 18,146.00 |
| Sep 30, 2024 | -10.70 Mn |
| Jun 30, 2024 | 60,150.00 |
| Mar 31, 2024 | -502,703.00 |
| Dec 31, 2023 | 53,696.00 |
| Sep 30, 2023 | -95,439.00 |
| Jun 30, 2023 | -123,578.00 |
| Mar 31, 2023 | 29,722.00 |
| Dec 31, 2022 | -64,979.00 |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | 67,753.00 |
| Mar 31, 2022 | 76,145.00 |
| Dec 31, 2021 | 9,533.00 |
| Sep 30, 2021 | -52,144.00 |
| Jun 30, 2021 | -1.41 Mn |
| Mar 31, 2021 | -7,162.00 |
| Sep 30, 2020 | 44,011.00 |
| Jun 30, 2020 | 55,168.00 |
| Mar 31, 2020 | 367,622.00 |
| Dec 31, 2019 | 402,028.00 |
| Sep 30, 2019 | 130,125.00 |
| Jun 30, 2019 | -96,329.00 |
| Mar 31, 2019 | 70,505.00 |
| Dec 31, 2018 | 113,321.00 |
| Sep 30, 2018 | 98,981.00 |
| Jun 30, 2018 | 568,721.00 |